Search

everythinglearnresearchcommunity

for

Search:↓

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Red ginseng oil is believed to have various health benefits and is safe, but more research is needed to fully understand how it works.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

Common skin conditions can greatly affect a person's mental health and social life.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

The link between anabolic agents and colorectal cancer risk is unclear.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Intersex frogs have different brain gene activity related to sex and thyroid hormones.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Matriptase is crucial for skin, hair, and immune cell health, and its imbalance can lead to cancer.

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

AKR1C enzymes in scalp glands decrease with age, possibly affecting hair loss.

Finasteride use in male rats may harm their male offspring's liver function.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Enzymes involved in Vitamin A metabolism affect hair growth and type in mice.

Testosterone use for muscle growth can cause hair loss in males.

Anabolic agents can cause cardiovascular and behavioral issues in athletes.